Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Maternal hyperthermia induced birth defects is a rare maternal disease-related embryofetopathy characterized by variable developmental anomalies of the fetus due to teratogenic effect of elevated maternal body temperature (resulting from febrile illness or hot environment exposure). Reported developmental anomalies include neural tube defects (spina bifida, ecephalocele, anencephaly), cardiac defects (transposition of great vessels), urogenital defects (hypospadias), abdominal wall defects, cleft lip/palate, eye defects (cataract, coloboma) or various minor anomalies (e.g., bifid uvula, preauricular pit or tag). Consensus regarding cause-effect relationship has not been reached.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for maternal hyperthermia induced birth defects.
50 publications have been identified in PubMed for maternal hyperthermia induced birth defects. Research spans Basic Science / Preclinical (56%), Case Report / Case Series (18%), and Review / Meta-Analysis (14%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 28 | 56% |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 5:04 PM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies
9 |
18% |
Research summaries | 7 | 14% |
New treatment approaches | 3 | 6% |
Disease patterns and progression | 2 | 4% |
Clinical study results | 1 | 2% |
Antić B (2026). [PMID: 41848626](https://pubmed.ncbi.nlm.nih.gov/41848626/). *J Mater Chem B*. [Basic Science / Preclinical]
Jin Y (2026). [PMID: 41401533](https://pubmed.ncbi.nlm.nih.gov/41401533/). *Colloids Surf B Biointerfaces*. [Basic Science / Preclinical]
Kathard R (2026). [PMID: 29262152](https://pubmed.ncbi.nlm.nih.gov/29262152/). *Unknown Journal*. [Basic Science / Preclinical]
Silva ABR (2026). [PMID: 40825259](https://pubmed.ncbi.nlm.nih.gov/40825259/). *Theriogenology*. [Gene Therapy / Novel Therapeutics]
El Oumary O (2026). [PMID: 41756567](https://pubmed.ncbi.nlm.nih.gov/41756567/). *Front Psychiatry*. [Case Report / Case Series]
Zhu Y (2026). [PMID: 41993635](https://pubmed.ncbi.nlm.nih.gov/41993635/). *Theranostics*. [Basic Science / Preclinical]
Ma D (2026). [PMID: 42064776](https://pubmed.ncbi.nlm.nih.gov/42064776/). *Front Endocrinol (Lausanne)*. [Review / Meta-Analysis]
Wang Y (2026). [PMID: 41787726](https://pubmed.ncbi.nlm.nih.gov/41787726/). *Birth Defects Res*. [Basic Science / Preclinical]
Sawangkum P (2026). [PMID: 41889365](https://pubmed.ncbi.nlm.nih.gov/41889365/). *Birth Defects Res*. [Review / Meta-Analysis]
Zhao J (2025). [PMID: 39738868](https://pubmed.ncbi.nlm.nih.gov/39738868/). *Adv Sci (Weinh)*. [Epidemiology / Natural History]
AI-curated news mentioning maternal hyperthermia induced birth defects
Updated May 21, 2009
Recent data highlights the ongoing issue of alcohol consumption during pregnancy, which is a significant contributor to birth defects. Awareness campaigns are crucial to address this public health concern.
A CDC study reveals that infants conceived through Assisted Reproductive Technology (ART) face a two to four times higher risk of specific birth defects compared to naturally conceived children. This finding underscores the need for further investigation into the safety of ART.
A study published in the American Journal of Obstetrics and Gynecology reveals that women diagnosed with diabetes before pregnancy face a three to four times higher risk of having children with birth defects. This research underscores the importance of managing pre-pregnancy diabetes to mitigate risks.